Join to View Full Profile
20 Prospect AveSte 507Hackensack, NJ 07601
Phone+1 201-487-4088
Fax+1 201-489-8930
Dr. Balani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Infectious Disease, 1998 - 2000
Muhlenberg Regional Medical CenterResidency, Internal Medicine, 1995 - 1998
Rural Medical College Pravara Institute of Medical SciencesClass of 1994
Certifications & Licensure
NJ State Medical License 2000 - 2025
PA State Medical License 1998 - 2002
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- A US-Based Multi-Site Pilot to Screen Hepatitis B Surface Antigen-Positive Patients for Hepatitis D.Maggie Li, Bijou Hunt, Bindu Balani, Chinwe Ogedegbe, Peter Gordon
Journal of Viral Hepatitis. 2025-01-01 - Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison From 2 Large, Open-Label Studies.Dahlene Fusco, Ivana Malenica, Huldrych F Günthard, Samir K Gupta, Dax Kurbegov
Clinical Infectious Diseases. 2024-11-22 - 26 citationsRemdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day MortalitySusan Olender, Theresa L. Walunas, Esteban Martínez, Katherine K. Perez, Antonella Castagna
Open Forum Infectious Diseases. 2021-05-26
Press Mentions
Inside the FDA Drug Development Process: The Limits of Clinical Trials in Preventing Side EffectsDecember 13th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
